DSM figures: five-year summary

Balance sheet

x € million
2018
2017
2016
2015
2014
           
Assets
         
           
Intangible assets
3,090
3,058
3,188
3,228
2,867
Property, plant and equipment
3,511
3,313
3,325
3,171
3,673
Deferred tax assets
248
281
355
366
427
Share in associates and joint ventures
205
227
586
644
617
Financial derivatives
14
16
-
32
23
Other financial assets
263
475
463
419
275
Non-current assets
7,331
7,370
7,917
7,860
7,882
           
Inventories
1,993
1,848
1,800
1,627
1,739
Current receivables
1,738
1,690
1,653
1,556
1,769
Financial derivatives
21
41
40
15
24
Current investments
1,277
954
944
9
6
Cash and cash equivalents
1,281
899
604
665
669
 
6,310
5,432
5,041
3,872
4,207
Assets held for sale
-
-
-
11
37
Current assets
6,310
5,432
5,041
3,883
4,244
           
Total assets
13,641
12,802
12,958
11,743
12,126
           
Equity and liabilities
         
           
Shareholders' equity
7,782
6,962
6,072
5,541
5,723
Non-controlling interests
33
103
108
90
213
Equity
7,815
7,065
6,180
5,631
5,936
           
Deferred tax liabilities
254
259
278
319
365
Employee benefit liabilities
413
356
490
496
479
Provisions
116
151
128
98
105
Borrowings
2,272
2,551
2,552
2,557
1,637
Financial derivatives
3
4
14
182
178
Other non-current liabilities
197
188
158
228
81
Non-current liabilities
3,255
3,509
3,620
3,880
2,845
           
Employee benefit liabilities
46
39
40
44
45
Provisions
37
53
54
41
42
Borrowings
380
77
853
253
1,143
Financial derivatives
51
20
239
50
184
Current liabilities
2,057
2,039
1,972
1,842
1,915
 
2,571
2,228
3,158
2,230
3,329
Liabilities held for sale
-
-
-
2
16
Current liabilities
2,571
2,228
3,158
2,232
3,345
           
Total equity and liabilities
13,641
12,802
12,958
11,743
12,126

Income statement

x € million
2018
2017
2016
2015
2014
           
Net sales underlying business1
8,852
8,632
7,920
7,722
7,051
Net sales
9,267
8,632
7,920
8,935
9,283
           
Adjusted EBITDA underlying business1
1,532
1,445
1,262
1,075
1,038
Adjusted EBITDA2
1,822
1,445
1,262
1,170
1,166
EBITDA
1,754
1,348
1,146
1,046
1,134
           
Adjusted operating profit (EBIT) underlying business1
1,055
957
791
573
587
Adjusted operating profit (EBIT)2
1,345
957
791
650
617
Operating profit (EBIT)
1,245
846
657
304
290
Financial income and expense
(101)
(104)
(133)
(174)
(125)
Income tax expense
(194)
(115)
(89)
(68)
(7)
Share of the profit of associates and joint ventures
129
1,154
194
30
(59)
           
Profit for the year
1,079
1,781
629
92
99
Profit attributable to non-controlling interests
2
12
8
4
(46)
           
Net profit attributable to equity holders of Koninklijke DSM N.V.
1,077
1,769
621
88
145
Dividend on cumulative preference shares
(8)
(8)
(4)
(10)
(10)
           
Net profit available to holders of ordinary shares
1,069
1,761
617
78
135
           
           
Key figures and financial ratios
         
Capital employed3
8,181
7,766
7,889
7,553
8,105
Capital expenditure:
         
- Intangible assets and Property, plant and equipment
653
586
485
570
616
- Acquisitions
51
204
16
106
-
Disposals
257
1,546
87
307
93
Depreciation, amortization and impairments
509
502
489
742
798
Net debt
(113)
(742)
(2,070)
(2,321)
(2,420)
Dividend
412
331
310
297
296
           
Workforce at 31 December, headcount
20,977
21,054
20,786
20,796
21,351
Employee benefit costs (x € million)
1,753
1,768
1,752
1,778
1,713
           
Financial ratios2
         
- ROCE in % underlying business1
13.3
12.3
10.4
7.6
8.2
- ROCE in %
16.8
12.3
10.4
8.2
7.8
- Net sales underlying business / average capital employed1
1.11
1.11
1.04
1.03
0.99
- Current assets / current liabilities
2.45
2.44
1.58
1.62
1.21
- Equity / total assets
0.57
0.55
0.48
0.48
0.49
- Gearing (net debt / equity plus net debt)
0.01
0.10
0.25
0.29
0.29
- Adjusted EBIT underlying business / net sales in % underlying business1
11.9
11.1
10.0
7.4
8.3
- Net profit / average Shareholders' equity available to holders of ordinary shares in %
24.7
28.0
11.1
1.4
2.4
- Adjusted EBITDA underlying business / Financial income and expense1
15.2
13.9
9.5
7.2
10.2

1 Continuing operations, excluding temporary vitamin effect 2018, see Key business figures at a glance.

2 In presenting and discussing DSM's financial position, operating results and cashflows, DSM uses certain Alternative performance measures (APMs) not defined by IFRS. These APMs are used because they are an important measure of DSM's business development and DSM's management performance. A full reconciliation of IFRS performance measures to the APMs is given in the Alternative performance measures.

3 Before reclassification to held for sale.

Information about ordinary DSM shares

per ordinary share in €
2018
2017
2016
2015
2014
           
Adjusted Net profit
5.84
3.92
2.90
2.14
2.34
Net profit
6.10
10.07
3.52
0.45
0.78
Operating cash flow
7.89
5.65
5.79
3.93
4.62
           
Dividend:
2.301
1.85
1.75
1.65
1.65
- Interim dividend
0.77
0.58
0.55
0.55
0.55
- Final dividend
1.53
1.27
1.20
1.10
1.10
           
Pay-out including dividend on cumulative preference shares as % of Adjusted net profit
40
48
61
71
69
Dividend yield (dividend as % of average price of an ordinary DSM share)
2.7
2.8
3.3
3.5
3.3
           
Share prices on Euronext Amsterdam (closing price):
         
- Highest price
92.98
81.66
64.18
55.11
57.97
- Lowest price
68.98
57.20
41.40
39.62
44.44
- At 31 December
71.44
79.67
56.96
46.28
50.64
           
           
(x 1,000)
         
Number of ordinary shares outstanding:
         
- At 31 December
175,651
174,643
175,002
174,923
173,537
- Average
175,323
174,795
175,100
174,357
172,605
           
Daily trading volumes on Euronext Amsterdam:
         
- Average
732
676
787
912
801
- Lowest
130
238
152
130
104
- Highest
2,617
2,110
2,554
4,506
7,981

1 Subject to approval by the Annual General Meeting of Shareholders